 double-blind trial podofilox placebo treatment genital warts women Patient-applied formulations podofilox podophyllotoxin treatment external genital warts double-blind placebo-controlled study Seventy-two women computer-generated list active drug placebo ratio Patients medication external warts day consecutive days days treatment cycle weekly intervals maximum weeks minimum weeks Patients evaluated weekly first month weeks number warts present overall improvement treated area patients adverse effects standard hematologic/biochemical studies final results podofilox total wart count regression placebo group investigators assessments improvement active drug placebo observation point Local untoward effects minor transient evidence systemic effects patient-applied podofilox safe effective therapy genital condylomata women available drug treatment genital warts patient-applied alternative therapy